Skip to content
Screener

Solesence, Inc. SLSN Q1 2025 Annual earnings

Reported May 5, 2025 · After market close

Revenue$14.6M
EPS$0.00

Next report

Nov 16, 2026 (in 3 months)

Financials

Q1 2025

Income statement

See full
Revenue$14.6M+48.2%
Gross profit$3.4M-5.5%
Operating income$256.0K-77.0%
Net income$343.0K-61.6%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$1.8M-10.0%
Total debt$10.1M-9.4%
Total equity$10.8M+119%
Total assets$57.0M+48.1%

Cash flow

See full
Operating cash flow-$7.2M-87.3%
CapEx-$133.0K-256%
Free cash flow-$7.4M-86.6%

Valuation & ratios

Profitability

See full
Gross margin28%+3.5pp
Operating margin7.9%+6.0pp

Returns & leverage

See full
Debt / equity0.9×-1.3×
Current ratio1.1×-0.7×

Segments

By product

See full
Consumer Products$12.9M+59.0%
Personal Care Ingredients$1.4M-0.2%
Advanced Materials$370.0K-4.6%

By geography

See full
Non Us$993.0K+245%

FAQ

When did Solesence, Inc. report Q1 2025 earnings?
Solesence, Inc. (SLSN) reported Q1 2025 earnings on May 5, 2025 after market close.
What were Solesence, Inc.'s Q1 2025 revenue and EPS?
Solesence, Inc. reported revenue of $14.6M and eps of $0.00 for Q1 2025.
How did Solesence, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 48.2% from $9.9M a year earlier and eps declined 91.6% from $0.01.
Where can I find Solesence, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001171843-25-002902) and the 10-K periodic report (0001999371-25-003471) directly on SEC EDGAR. The filing index links above go to sec.gov.